Angiotensin II Receptor Blocker (ARBs) API Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Angiotensin II Receptor Blocker (ARBs) API Market is anticipated to gain exponential industry growth over the given forecast period of 2022-2028.

Angiotensin II receptor blockers (ARBs) help block the action of angiotensin II, which causes blood vessels to dilate. Angiotensin II is a chemical in the body that affects the heart by narrowing the blood vessels, preventing blood from moving through the necessary spaces, raising blood pressure, known as high blood pressure, and leading to cardiovascular risk. The leading brands in the ARB market are Benicar (olmesartan medoxomil), Diovan (valsartan), Micardis (telmisartan), Cozaar (Osartan), Edarbi (Azilsartan), Atacand (candesartan), Teveten (eprosartan), and Avapro (irbesartan). ARBs are helpful in the treatment of conditions such as high blood pressure, heart failure, chronic kidney disease, and kidney failure in diabetes. Hypertension and cardiovascular risk are correlated. An increase in blood pressure can lead to a high cardiovascular risk for the patient. According to the World Health Organization, blood pressure is the most common cause of heart failure and increases mortality.

Market Segments

By Type

• Valsartan
• Irbesartan
• Telmisartan
• Losartan
• Candesartan
• Olmesartan
• Others

By Application

• Essential Hypertension
• Secondary Hypertension

Key Players

• Teva Pharmaceutical
• Aurobindo Pharma
• Viatris
• Tianyu Pharma
• Huahai Pharmaceutical
• Menovo
• Rundu Pharma
• Kinglyuan Pharmaceutical
• Second Pharma
• Apeloa
• Jiangxi Synergy Pharmaceutical

Scope of the Report

The research study analyzes the global Angiotensin II Receptor Blocker (ARBs) API industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Angiotensin II Receptor Blocker (ARBs) API Market Report

1. What was the Angiotensin II Receptor Blocker (ARBs) API Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Angiotensin II Receptor Blocker (ARBs) API Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Angiotensin II Receptor Blocker (ARBs) API Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.